Publications by the researcher in collaboration with Y. Quiros (9)

2024

  1. Urinary GM2AP coincides with renal cortical damage and grades cisplatin nephrotoxicity severity in rats

    Toxicology, Vol. 508

2021

  1. Urinary Plasminogen Activator Inhibitor-1: A Biomarker of Acute Tubular Injury

    American Journal of Nephrology, Vol. 52, Núm. 9, pp. 714-724

2020

  1. Combined use of GM2AP and TCP1-eta urinary levels predicts recovery from intrinsic acute kidney injury

    Scientific Reports, Vol. 10, Núm. 1

  2. Impaired Tubular Reabsorption Is the Main Mechanism Explaining Increases in Urinary NGAL Excretion Following Acute Kidney Injury in Rats

    Toxicological sciences : an official journal of the Society of Toxicology, Vol. 175, Núm. 1, pp. 75-86

2019

  1. Preventive effect of cardiotrophin-1 administration before DSS-induced ulcerative colitis in mice

    Journal of Clinical Medicine, Vol. 8, Núm. 12

2018

  1. Cardiotrophin-1 attenuates experimental colitis in mice

    Clinical Science, Vol. 132, Núm. 9, pp. 985-1001

2016

  1. Cardiotrophin-1 therapy prevents gentamicin-induced nephrotoxicity in rats

    Pharmacological Research, Vol. 107, pp. 137-146

2015

  1. Increased Klk9 urinary excretion is associated to hypertension-induced cardiovascular damage and renal alterations

    Medicine (United States), Vol. 94, Núm. 41

2014

  1. Hypertension and hyperglycemia synergize to cause incipient renal tubular alterations resulting in increased NGAL urinary excretion in rats

    PLoS ONE, Vol. 9, Núm. 8